TY - JOUR AU - Franco, Pierfrancesco AU - Ricardi, Umberto PY - 2019 TI - Primary tumor size as a prognosticator in anal cancer patients JF - Annals of Translational Medicine; Vol 7, No 7 (April 15, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - Combination therapy with concurrent chemo-radiation is considered the standard therapeutic option for anal cancer patients, providing both tumor eradication and sphincter preservation (1). Survival rates depend on the global stage at presentation ranging from 60% to 80% at 3–5 years (2-4). UR - https://atm.amegroups.org/article/view/24413